Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
This Quarter Return
-2.67%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$23.7B
AUM Growth
+$23.7B
Cap. Flow
+$2.21B
Cap. Flow %
9.33%
Top 10 Hldgs %
31.04%
Holding
1,343
New
56
Increased
717
Reduced
258
Closed
49

Sector Composition

1 Real Estate 35.46%
2 Technology 23.73%
3 Communication Services 9.02%
4 Consumer Discretionary 6.33%
5 Financials 6.33%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
KALV icon
1176
KalVista Pharmaceuticals
KALV
$719M
$2K ﹤0.01%
154
KURA icon
1177
Kura Oncology
KURA
$690M
$2K ﹤0.01%
297
MGTX icon
1178
MeiraGTx Holdings
MGTX
$587M
$2K ﹤0.01%
330
+200
+154% +$1.21K
MLYS icon
1179
Mineralys Therapeutics
MLYS
$1.91B
$2K ﹤0.01%
152
OMER icon
1180
Omeros
OMER
$292M
$2K ﹤0.01%
191
PHAT icon
1181
Phathom Pharmaceuticals
PHAT
$841M
$2K ﹤0.01%
260
PRAX icon
1182
Praxis Precision Medicines
PRAX
$946M
$2K ﹤0.01%
62
PRTA icon
1183
Prothena Corp
PRTA
$445M
$2K ﹤0.01%
195
QURE icon
1184
uniQure
QURE
$933M
$2K ﹤0.01%
158
RCKT icon
1185
Rocket Pharmaceuticals
RCKT
$350M
$2K ﹤0.01%
304
REPL icon
1186
Replimune Group
REPL
$461M
$2K ﹤0.01%
200
SAGE
1187
DELISTED
Sage Therapeutics
SAGE
$2K ﹤0.01%
239
SHY icon
1188
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
$2K ﹤0.01%
19
-160
-89% -$16.8K
SVRA icon
1189
Savara
SVRA
$572M
$2K ﹤0.01%
553
TBPH icon
1190
Theravance Biopharma
TBPH
$697M
$2K ﹤0.01%
215
TKNO icon
1191
Alpha Teknova
TKNO
$226M
$2K ﹤0.01%
+300
New +$2K
TRVI icon
1192
Trevi Therapeutics
TRVI
$885M
$2K ﹤0.01%
+305
New +$2K
TYRA icon
1193
Tyra Biosciences
TYRA
$668M
$2K ﹤0.01%
+173
New +$2K
URGN icon
1194
UroGen Pharma
URGN
$904M
$2K ﹤0.01%
160
XERS icon
1195
Xeris Biopharma Holdings
XERS
$1.28B
$2K ﹤0.01%
404
XNCR icon
1196
Xencor
XNCR
$610M
$2K ﹤0.01%
222
AVBP icon
1197
ArriVent BioPharma
AVBP
$805M
$2K ﹤0.01%
111
LENZ
1198
LENZ Therapeutics
LENZ
$1.12B
$2K ﹤0.01%
91
ABUS icon
1199
Arbutus Biopharma
ABUS
$732M
$1K ﹤0.01%
395
ALT icon
1200
Altimmune
ALT
$331M
$1K ﹤0.01%
235